Industry News
Heparin - Possible Cancer Treatment
Feb 15, 2012
Although the blood thinner heparin has been used for several decades to prevent and treat blood clots, researchers are now questioning whether the drug could be effective in treating cancer... Read More
Heparin - Possible Cancer Treatment
Feb 15, 2012
Although the blood thinner heparin has been used for several decades to prevent and treat blood clots, researchers are now questioning whether the drug could be effective in treating cancer... Read More
AL Amyloidosis - Bortezomib, Cyclophosphamide, And Dexamethasone Combo Shows Promise
Feb 15, 2012
Two studies have registered a preliminary success of an effective multiple myeloma (MM) regimen in patients with AL amyloidosis. The studies have been published in Blood, the Journal of the American Society of Hematology (ASH)... Read More
AL Amyloidosis - Bortezomib, Cyclophosphamide, And Dexamethasone Combo Shows Promise
Feb 15, 2012
Two studies have registered a preliminary success of an effective multiple myeloma (MM) regimen in patients with AL amyloidosis. The studies have been published in Blood, the Journal of the American Society of Hematology (ASH)... Read More
Bureaucracy May Be Putting Lives At Risk, Europe
Feb 15, 2012
A European Parliament event to discuss how EU legislation has negatively affected the treatment received by children and adolescents has marked International Childhood Cancer Day - 15th February... Read More
Computational Algorithm Developed To Assist In Cancer Treatments
Feb 15, 2012
High-throughput DNA sequencing technologies are leading to a revolution in how clinicians diagnose and treat cancer. The molecular profiles of individual tumors are beginning to be used in the design of chemotherapeutic programs optimized for the treatment of individual patients... Read More
First Prospective Analysis Links Breast And Pancreatic Cancer Risk With Lynch Syndrome
Feb 15, 2012
A new prospective study of patients with Lynch syndrome - an inherited disorder of cancer susceptibility caused by mutations in specific DNA repair genes - provides the first strong evidence that people with Lynch syndrome face significantly increased risks of breast and pancreatic cancers... Read More
Increase In Injectable Treatment For Blood Clots In Advanced Cancer Patients
Feb 15, 2012
The use of an injectable, clot-preventing drug known as Low Molecular Weight Heparin to treat patients with advanced cancer complicated by blood clots increased steadily between 2000 and 2007, according to a new study published in The Oncologist, funded by the National Cancer Institute and led by Kaiser Permanente Colorado... Read More
Patients With AL Amyloidosis May Benefit From Powerful Myeloma Treatment Regimen
Feb 15, 2012
Two studies published in Blood, the Journal of the American Society of Hematology (ASH), demonstrate preliminary success of an effective multiple myeloma (MM) regimen in patients with AL amyloidosis, a rare and devastating blood disease that results in deposition of damaging abnormal protein in critical organs of the body, including the kidneys, heart, liver, and intestines, an... Read More
Increase In Injectable Treatment For Blood Clots In Advanced Cancer Patients
Feb 15, 2012
The use of an injectable, clot-preventing drug known as Low Molecular Weight Heparin to treat patients with advanced cancer complicated by blood clots increased steadily between 2000 and 2007, according to a new study published in The Oncologist, funded by the National Cancer Institute and led by Kaiser Permanente Colorado... Read More
Previous Page Next Page